Body weight is regulated by the brain: a link between feeding and emotion T Kishi and JK Elmquist Despite its importance to survival, energy homeostasis is affected in a number of mentally ill patients. Obesity due to overnutrition is an increasing worldwide public health problem. It is now established that the brain receives and processes peripheral metabolic cues to regulate food intake and body weight. The authors illustrated two relevant hypothalamic systems potentially coregulating emotion and motivated behavior and discussed the significance of multidisciplinary molecular/neuroanatomic techniques to address the aforementioned issues.
MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed E Geuze, E Vermetten, JD Bremner
The advance of neuroimaging techniques has resulted in a burgeoning of studies reporting abnormalities in brain structure and function in a number of neuropsychiatric disorders. The authors reviewed the literature and selected all English-language, datadriven papers on hippocampal volumetry. The methodology of all original manual tracing protocols was studied. These protocols differed in a number of important factors for accurate hippocampal volume determination related to image acquisition, processing, and anatomical guidelines. The findings were discussed in relation to optimizing determination of hippocampal volume.
MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders E Geuze, E Vermetten, JD Bremner Magnetic resonance imaging (MRI) has opened a new window to the brain. Measuring hippocampal volume with MRI has provided important information about several neuropsychiatric disorders. The authors reviewed the literature and selected all Englishlanguage, human subject, data-driven papers on hippocampal volumetry, yielding a database of 423 records. Hippocampal volumetric findings for all neuropsychiatric disorders included were reported. Possible mechanisms of hippocampal volume loss in the major neuropsychiatric disorders were discussed.
Active zones for presynaptic plasticity in the brain P Garcı´a-Junco-Clemente, P Linares-Clemente, R Ferna´ndez-Chacón Garcia-Junco-Clemente et al reviewed presynaptic mechanisms of synaptic plasticity where an enhancement of neurotransmitter occurs. A paradigmatic example takes place at the hippocampal mossy fibers, where long-term potentiation is expressed and induced at the presynaptic terminals. Recent exciting findings revealed that active zone proteins act as downstream effectors to induce plastic changes in neurotransmitter release and emerge as potential targets to convey long-term changes in synaptic structure.
ORIGINAL RESEARCH ARTICLES
Hippocampal a5 subunit-containing GABA A receptors modulate the expression of prepulse inhibition J Hauser, U Rudolph, R Keist, H Mo¨hler, J Feldon, BK Yee A partial reduction of a5 GABA A receptors specific to the hippocampus, induced by a point mutation introduced to the GABA A a5 subunit, was associated with a deficit in sensorimotor gating in the form of reduced prepulse inhibition, and an enhancement of spontaneous locomotor activity. These phenotypes resemble the attentional deficit in schizophrenia and the effects of psychostimulants, suggesting a possible involvement of hippocampal a5 GABA A receptor in the genesis of psychotic symptoms and its potential as a novel target for antipsychotic action.
BDNF gene is a risk factor for schizophrenia in a Scottish population M Neves-Pereira, JK Cheung, A Pasdar, F Zhang, G Breen, P Yates, M Sinclair, C Crombie, N Walker, DM St Clair Brain-derived neurotrophic factor (BDNF) gene encoding a protein has been implicated in schizophrenia and mood disorders. The authors looked for association with variants of the BDNF gene in 321 schizophrenics, 263 bipolar cases, and 350 controls. They found that one variant was significantly associated with schizophrenia. When haplotypes or combinations of variants were examined, one haplotype was significantly increased and a second significantly decreased in schizophrenia. BDNF gene may affect risk of schizophrenia.
Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients KMR Prasad, KV Chowdari, VL Nimgaonkar, ME Talkowski, DA Lewis, MS Keshavan
Genetic variations of the RGS4 may confer risk for schizophrenia. RGS4 underexpression in the dorsolateral prefrontal cortex (DLPFC) of schizophrenia patients relative to controls is significant because DLPFC pathology in schizophrenia has been consistently shown. The authors examined the association of DLPFC gray matter volume with RGS4 variations in schizophrenia patients and control subjects. They observed robust volumetric differences across the genotypes within patients but not in control subjects. The findings suggest that RGS4 polymorphisms may contribute to DLPFC structural alterations.
Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden HJ Grabe, M Lange, B Wolff, H Völzke, M Lucht, HJ Freyberger, U John, I Cascorbi Grabe et al investigated the putative role of a geneenvironment interaction between the functional polymorphism of the promoter region of the serotonin transporter gene (SLC6A4), the employment status and the chronic disease burden in a community sample of 1005 subjects. Females carrying the short allele showed significantly higher mental and physical distress in the presence of these stressors than females without the short allele. These results extend previous findings on a gene-environment interaction of the SCL6A4 gene.
